
Artificial Heart Market Size, Share, and Outlook, H2-2025 Report- By Type (Ventricular Assist Device, Total Artificial Heart, Heart-Lung Machine, Others), By Power Source (Internal Battery, External Battery), By End-User (Hospitals and Clinics, Specialty
Description
Artificial Heart Market Outlook
The global Artificial Heart Market Size is valued at $3.2 Billion in 2025 and is forecast to reach $6.9 Billion in 2032 at a CAGR of 11.5%.
The Artificial Heart Market continue to remain a steadily growing market and offers lucrative growth opportunities across the industry stakeholders from suppliers to distributors and end-use industries. This comprehensive market research report provides 12-year historic and forecast data on Artificial Heart Market segments across 22 countries from 2021 to 2032. Key segments covered include By Type (Ventricular Assist Device, Total Artificial Heart, Heart-Lung Machine, Others), By Power Source (Internal Battery, External Battery), By End-User (Hospitals and Clinics, Specialty Clinics), offering granular insights into performance drivers and emerging patterns. With over 70 tables and charts, the report provides actionable findings based on extensive data modeling and industry surveys.
Artificial Heart Market Insights, 2025
Mechanical circulatory support in 2025 emphasizes smaller pumps, quieter operation, and less thrombosis. Total artificial heart programs are iterating on hemocompatible surfaces and pulsatility algorithms to reduce anticoagulation intensity. Ventricular assist devices are moving toward fully implantable architectures using transcutaneous energy transfer, eliminating percutaneous drivelines for select candidates. Remote monitoring dashboards now flag flow anomalies, power draw changes, and hemolysis indicators, enabling earlier interventions. Destination therapy eligibility continues to widen as centers publish survival and quality-of-life data under standardized rehab pathways. Surgeons report shorter ICU stays with refined weaning and extubation protocols and improved right-heart management. Supply-chain risk planning—redundant controllers, battery logistics, and service coverage—remains a key procurement criterion. Training expands to community hospitals via proctoring and simulation, supporting regionalization without compromising outcomes.
Five Trends Shaping the Global Artificial Heart Market in 2025 and Beyond
The global Artificial Heart Industry is undergoing a paradigm shift driven by regulatory changes, technological innovation, and sustainability imperatives. Amidst intense demand growth from diverse end-users, companies are focusing on new product launches to cater to individual applications. Companies are also emphasizing operational resilience and circular economy principles and are aligning strategies to secure long-term growth. The report identifies key structural changes, disruptive technologies, and evolving trade flows influencing competitiveness, helping stakeholders strengthen decision-making for both the short and long term.
What are the Biggest Opportunities for Growth in the Artificial Heart Industry?
The Artificial Heart Market sector has shown strong adaptability amid volatility in prices, supply chain disruptions, and geopolitical tensions. Moving forward, potential opportunities lie in niche products, aggressive distribution activities, and digital process optimization. With increasing demand from emerging markets, Artificial Heart Market is positioned for growth through 2030 and beyond. This chapter provides a strategic perspective for businesses to identify revenue-generating avenues, mitigate risks, and adopt innovative pathways for expansion.
Artificial Heart Market Segment Insights
The Artificial Heart Industry offers diverse opportunities across product types, applications, and distribution channels. The analytical report provides detailed forecasts across diverse segments including By Type (Ventricular Assist Device, Total Artificial Heart, Heart-Lung Machine, Others), By Power Source (Internal Battery, External Battery), By End-User (Hospitals and Clinics, Specialty Clinics). Insights cover the largest and fastest-growing product types, applications, and regions, highlighting drivers behind each segment. Market outlooks are provided for five regions—Asia Pacific, North America, Europe, South America, and Middle East & Africa—with country-level forecasts for 22 markets through 2032.
Artificial Heart Industry Value Chain
The chapter identifies potential companies and their operations across the global Artificial Heart Industry ecosystem. It assists decision-makers in evaluating global Artificial Heart Market fundamentals, market dynamics, and disruptive trends across the value chain segments. According to the International Council of Chemical Associations (ICCA), chemicals underpin over 95% of manufactured products worldwide.
Scenario Analysis and Forecasts
Strategic planning in the Artificial Heart Industry requires resilience to uncertain macroeconomic and regulatory conditions. To guide stakeholders, the report offers three scenario forecasts—low growth, reference case, and high growth—enabling companies to align strategies under different market conditions.
Asia Pacific Artificial Heart Market Analysis – Hub of Industrial Transformation
Asia Pacific continues to be the largest and fastest-growing region for Artificial Heart Market, underpinned by rapid industrialization, large-scale infrastructure development, and rising consumption across emerging economies. China, India, and Southeast Asia lead the demand surge, supported by investments in chemical parks, free trade agreements, and rising domestic manufacturing capacity. China remains the single largest producer and consumer of chemicals, accounting for over $1.5 trillion in chemical sales, followed by India, which is projected by the India Brand Equity Foundation (IBEF) to become a $300 billion chemicals market by 2025. Further, Japanese and South Korean markets remain stable with most companies focusing on new product launches and diversification of sales channels.
United States Artificial Heart Market Insights – Innovation and Specialty Leadership
The American Chemistry Council (ACC) projects steady annual demand growth for specialty and performance chemicals, particularly in automotive, electronics, agriculture, and construction applications. The US continues to lead in specialty and high-value-added chemicals, with investments focused on R&D, advanced process technologies, and digital manufacturing. In addition, the Canadian and Mexican markets offer lucrative growth pockets for manufacturers and vendors. Focus on private-brand offerings and promotions, diversified sales channels, expansion into niche segments, adoption of advanced technologies, and sustainability are widely observed across the North American Artificial Heart Market.
Europe Artificial Heart Market Outlook 2025 – Regulatory and Innovation-Driven Growth
Europe is one of the largest markets for Artificial Heart Market with demand from both Western Europe and Eastern European regions increasing over the medium to long-term future. The European chemical sector employs more than 1.2 million people directly and is highly influenced by the EU Green Deal, which aims for climate neutrality by 2050. With increasing adoption of advanced technologies, raw materials, and digital transformation, Europe remains a strategic hub for Artificial Heart Industry competitiveness. The report analyses the key Artificial Heart Market drivers and opportunities across Germany, France, the United Kingdom, Spain, Italy, Russia, and other Europe.
Latin American Artificial Heart Market outlook rebounds in line with economic growth
Optimistic economic outlook across Brazil, Argentina, Chile, and other South and Central American countries presents strong opportunities for domestic and international Artificial Heart Market companies. Increased consumer spending is estimated across markets over the next few quarters through 2026. Expanding trade partnerships, urbanization, and growing demand for specialty products underpin market prospects.
Middle East and Africa Artificial Heart Markets- New Opportunities for Companies Harnessing Diversity
The Middle East remains a key hub for Artificial Heart Market companies, with Saudi Arabia, UAE, and Qatar investing heavily in distribution networks. In addition, Africa presents strong growth potential in Nigeria, South Africa, and other emerging economies, with increasing demand for cost effective and accessible products. Investment strategies tailored to localized needs and sustainable growth will be crucial for success. In addition to Nigeria, Algeria, South Africa, and other markets, steady growth markets in Ethiopia, Rwanda, Ghana, Tanzania, the Democratic Republic of Congo, and others present significant prospects for companies.
Competitive Landscape – How Artificial Heart Market Companies Outcompete in 2025
The ability to adapt to changing regulations, sustainability imperatives, and customer-specific innovations defines leadership in the Artificial Heart Market. Companies are leveraging M&A activities, strategic joint ventures, and vertical integration to secure raw material access and strengthen downstream presence. The report profiles leading players, analyzing their 2024 revenues, market shares, R&D expenditures, and strategic directions. The report analyzes Abbott Laboratories, Abiomed, Berlin Heart Inc, BiVACOR Inc, Calon Cardio-Technology Ltd, Carmat, CryoLife Inc, Jarvik Heart Inc, ReinHeart TAH GmbH, SynCardia Systems Llc. Each company is benchmarked through a detailed SWOT and financial analysis, providing clients with insights into competitive positioning and innovation leadership.
Artificial Heart Market Scope
Leading Segments
By Type
Ventricular Assist Device
Total Artificial Heart
Heart-Lung Machine
Others
By Power Source
Internal Battery
External Battery
By End-User
Hospitals and Clinics
Specialty Clinics
Leading Companies
Abbott Laboratories
Abiomed
Berlin Heart Inc
BiVACOR Inc
Calon Cardio-Technology Ltd
Carmat
CryoLife Inc
Jarvik Heart Inc
ReinHeart TAH GmbH
SynCardia Systems Llc
Geographies
North America- US, Canada, Mexico
Europe- Germany, France, UK, Spain, Italy, Nordics, BeNeLux, Others
Asia Pacific- China, India, Japan, South Korea, Australia, South East Asia, Others
Latin America- Brazil, Argentina, Others
Middle East and Africa- Saudi Arabia, UAE, Other Middle East, South Africa, Other Africa
Reasons to Buy the Report Make informed decisions with 12-year forecasts across 22 countries and multiple market segments. Evaluate regulatory impacts, sustainability trends, and disruptive technologies shaping the chemicals industry. Gain insights into the competitive landscape, including company profiles, financials, and strategic moves. Build an integrated understanding of the chemicals ecosystem across upstream, midstream, and downstream operations. Leverage insights on circular economy initiatives, digitalization, and carbon-neutral strategies driving the next decade. Assess risks and opportunities with scenario-based forecasts tailored to different growth conditions. Access the report in multiple formats (PDF, Excel, PPT) for easier integration into strategic planning.
The global Artificial Heart Market Size is valued at $3.2 Billion in 2025 and is forecast to reach $6.9 Billion in 2032 at a CAGR of 11.5%.
The Artificial Heart Market continue to remain a steadily growing market and offers lucrative growth opportunities across the industry stakeholders from suppliers to distributors and end-use industries. This comprehensive market research report provides 12-year historic and forecast data on Artificial Heart Market segments across 22 countries from 2021 to 2032. Key segments covered include By Type (Ventricular Assist Device, Total Artificial Heart, Heart-Lung Machine, Others), By Power Source (Internal Battery, External Battery), By End-User (Hospitals and Clinics, Specialty Clinics), offering granular insights into performance drivers and emerging patterns. With over 70 tables and charts, the report provides actionable findings based on extensive data modeling and industry surveys.
Artificial Heart Market Insights, 2025
Mechanical circulatory support in 2025 emphasizes smaller pumps, quieter operation, and less thrombosis. Total artificial heart programs are iterating on hemocompatible surfaces and pulsatility algorithms to reduce anticoagulation intensity. Ventricular assist devices are moving toward fully implantable architectures using transcutaneous energy transfer, eliminating percutaneous drivelines for select candidates. Remote monitoring dashboards now flag flow anomalies, power draw changes, and hemolysis indicators, enabling earlier interventions. Destination therapy eligibility continues to widen as centers publish survival and quality-of-life data under standardized rehab pathways. Surgeons report shorter ICU stays with refined weaning and extubation protocols and improved right-heart management. Supply-chain risk planning—redundant controllers, battery logistics, and service coverage—remains a key procurement criterion. Training expands to community hospitals via proctoring and simulation, supporting regionalization without compromising outcomes.
Five Trends Shaping the Global Artificial Heart Market in 2025 and Beyond
The global Artificial Heart Industry is undergoing a paradigm shift driven by regulatory changes, technological innovation, and sustainability imperatives. Amidst intense demand growth from diverse end-users, companies are focusing on new product launches to cater to individual applications. Companies are also emphasizing operational resilience and circular economy principles and are aligning strategies to secure long-term growth. The report identifies key structural changes, disruptive technologies, and evolving trade flows influencing competitiveness, helping stakeholders strengthen decision-making for both the short and long term.
What are the Biggest Opportunities for Growth in the Artificial Heart Industry?
The Artificial Heart Market sector has shown strong adaptability amid volatility in prices, supply chain disruptions, and geopolitical tensions. Moving forward, potential opportunities lie in niche products, aggressive distribution activities, and digital process optimization. With increasing demand from emerging markets, Artificial Heart Market is positioned for growth through 2030 and beyond. This chapter provides a strategic perspective for businesses to identify revenue-generating avenues, mitigate risks, and adopt innovative pathways for expansion.
Artificial Heart Market Segment Insights
The Artificial Heart Industry offers diverse opportunities across product types, applications, and distribution channels. The analytical report provides detailed forecasts across diverse segments including By Type (Ventricular Assist Device, Total Artificial Heart, Heart-Lung Machine, Others), By Power Source (Internal Battery, External Battery), By End-User (Hospitals and Clinics, Specialty Clinics). Insights cover the largest and fastest-growing product types, applications, and regions, highlighting drivers behind each segment. Market outlooks are provided for five regions—Asia Pacific, North America, Europe, South America, and Middle East & Africa—with country-level forecasts for 22 markets through 2032.
Artificial Heart Industry Value Chain
The chapter identifies potential companies and their operations across the global Artificial Heart Industry ecosystem. It assists decision-makers in evaluating global Artificial Heart Market fundamentals, market dynamics, and disruptive trends across the value chain segments. According to the International Council of Chemical Associations (ICCA), chemicals underpin over 95% of manufactured products worldwide.
Scenario Analysis and Forecasts
Strategic planning in the Artificial Heart Industry requires resilience to uncertain macroeconomic and regulatory conditions. To guide stakeholders, the report offers three scenario forecasts—low growth, reference case, and high growth—enabling companies to align strategies under different market conditions.
Asia Pacific Artificial Heart Market Analysis – Hub of Industrial Transformation
Asia Pacific continues to be the largest and fastest-growing region for Artificial Heart Market, underpinned by rapid industrialization, large-scale infrastructure development, and rising consumption across emerging economies. China, India, and Southeast Asia lead the demand surge, supported by investments in chemical parks, free trade agreements, and rising domestic manufacturing capacity. China remains the single largest producer and consumer of chemicals, accounting for over $1.5 trillion in chemical sales, followed by India, which is projected by the India Brand Equity Foundation (IBEF) to become a $300 billion chemicals market by 2025. Further, Japanese and South Korean markets remain stable with most companies focusing on new product launches and diversification of sales channels.
United States Artificial Heart Market Insights – Innovation and Specialty Leadership
The American Chemistry Council (ACC) projects steady annual demand growth for specialty and performance chemicals, particularly in automotive, electronics, agriculture, and construction applications. The US continues to lead in specialty and high-value-added chemicals, with investments focused on R&D, advanced process technologies, and digital manufacturing. In addition, the Canadian and Mexican markets offer lucrative growth pockets for manufacturers and vendors. Focus on private-brand offerings and promotions, diversified sales channels, expansion into niche segments, adoption of advanced technologies, and sustainability are widely observed across the North American Artificial Heart Market.
Europe Artificial Heart Market Outlook 2025 – Regulatory and Innovation-Driven Growth
Europe is one of the largest markets for Artificial Heart Market with demand from both Western Europe and Eastern European regions increasing over the medium to long-term future. The European chemical sector employs more than 1.2 million people directly and is highly influenced by the EU Green Deal, which aims for climate neutrality by 2050. With increasing adoption of advanced technologies, raw materials, and digital transformation, Europe remains a strategic hub for Artificial Heart Industry competitiveness. The report analyses the key Artificial Heart Market drivers and opportunities across Germany, France, the United Kingdom, Spain, Italy, Russia, and other Europe.
Latin American Artificial Heart Market outlook rebounds in line with economic growth
Optimistic economic outlook across Brazil, Argentina, Chile, and other South and Central American countries presents strong opportunities for domestic and international Artificial Heart Market companies. Increased consumer spending is estimated across markets over the next few quarters through 2026. Expanding trade partnerships, urbanization, and growing demand for specialty products underpin market prospects.
Middle East and Africa Artificial Heart Markets- New Opportunities for Companies Harnessing Diversity
The Middle East remains a key hub for Artificial Heart Market companies, with Saudi Arabia, UAE, and Qatar investing heavily in distribution networks. In addition, Africa presents strong growth potential in Nigeria, South Africa, and other emerging economies, with increasing demand for cost effective and accessible products. Investment strategies tailored to localized needs and sustainable growth will be crucial for success. In addition to Nigeria, Algeria, South Africa, and other markets, steady growth markets in Ethiopia, Rwanda, Ghana, Tanzania, the Democratic Republic of Congo, and others present significant prospects for companies.
Competitive Landscape – How Artificial Heart Market Companies Outcompete in 2025
The ability to adapt to changing regulations, sustainability imperatives, and customer-specific innovations defines leadership in the Artificial Heart Market. Companies are leveraging M&A activities, strategic joint ventures, and vertical integration to secure raw material access and strengthen downstream presence. The report profiles leading players, analyzing their 2024 revenues, market shares, R&D expenditures, and strategic directions. The report analyzes Abbott Laboratories, Abiomed, Berlin Heart Inc, BiVACOR Inc, Calon Cardio-Technology Ltd, Carmat, CryoLife Inc, Jarvik Heart Inc, ReinHeart TAH GmbH, SynCardia Systems Llc. Each company is benchmarked through a detailed SWOT and financial analysis, providing clients with insights into competitive positioning and innovation leadership.
Artificial Heart Market Scope
Leading Segments
By Type
Ventricular Assist Device
Total Artificial Heart
Heart-Lung Machine
Others
By Power Source
Internal Battery
External Battery
By End-User
Hospitals and Clinics
Specialty Clinics
Leading Companies
Abbott Laboratories
Abiomed
Berlin Heart Inc
BiVACOR Inc
Calon Cardio-Technology Ltd
Carmat
CryoLife Inc
Jarvik Heart Inc
ReinHeart TAH GmbH
SynCardia Systems Llc
Geographies
North America- US, Canada, Mexico
Europe- Germany, France, UK, Spain, Italy, Nordics, BeNeLux, Others
Asia Pacific- China, India, Japan, South Korea, Australia, South East Asia, Others
Latin America- Brazil, Argentina, Others
Middle East and Africa- Saudi Arabia, UAE, Other Middle East, South Africa, Other Africa
Reasons to Buy the Report
Table of Contents
181 Pages
- 1. Table of Contents
- List of Figures and Tables
- 2. Executive Summary
- 2.1 Key Highlights
- 2.1.1 Artificial Heart Market Size Outlook, 2018-2024 and 2025-2032
- 2.1.2 Largest Artificial Heart Market Types and Applications
- 2.1.3 Fastest Growing Segments
- 2.1.4 Potential Markets
- 2.1.5 Market Concentration
- 2.2 Market Scope and Segmentation
- 2.2.1 Market Scope- Segments
- 2.2.2 Market Scope- Countries
- 2.2.3 Macroeconomic and Demographic Outlook
- 2.2.4 Abbreviations
- 2.2.5 Units and Currency Conversions
- 3. Research Methodology
- 3.1 Primary Research Surveys
- 3.2 Secondary Data Sources
- 3.3 Data Triangulation
- 3.4 Forecast Methodology
- 3.5 Assumptions and Limitations
- 4. Introduction to Global Artificial Heart Market in 2025
- 4.1 Industry Panorama
- 4.2 Leading Companies Profiled in the Study
- 4.3 Asia Pacific Markets offer Robust Market Prospects for New Entrants
- 4.4 Market Dynamics
- 4.4.1 Market Dynamics- Trends and Drivers
- 4.4.2 Market Dynamics- Opportunities and Challenges
- 4.5 Regional Analysis
- 4.6 Porter’s Five Force Analysis
- 4.6.1 Intensity of Competitive Rivalry
- 4.6.2 Threat of New Entrants
- 4.6.3 Threat of Substitutes
- 4.6.4 Bargaining Power of Buyers
- 4.6.5 Bargaining Power of Suppliers
- 4.7 Artificial Heart Market Industry Value Chain Analysis
- 4.7.1 Stage of Value Chain
- 4.7.2 Key Activities of Companies
- 4.7.3 Companies Included in Each Stage
- 4.7.4 Key Insights
- 5. Artificial Heart Market Outlook to 2032
- 5.1 Market Size Forecast by Type, 2021-2024 and 2025-2032
- 5.2 Market Size Forecast by Application, 2021-2024 and 2024-2032
- 5.3 Market Size Forecast by Geography, 2021-2024 and 2024-2032
- By Type
- Ventricular Assist Device
- Total Artificial Heart
- Heart-Lung Machine
- Others
- By Power Source
- Internal Battery
- External Battery
- By End-User
- Hospitals and Clinics
- Specialty Clinics
- 6. Global Artificial Heart Market Outlook across Growth Scenarios
- 6.1 Low Growth Scenario
- 6.2 Base/Reference Case
- 6.3 High Growth Scenario
- 6. North America Artificial Heart Market Size Outlook
- 6.1 Key Market Statistics, 2024
- 6.2 North America Artificial Heart Market Trends and Growth Opportunities
- 6.2.1 North America Artificial Heart Market Outlook by Type
- 6.2.2 North America Artificial Heart Market Outlook by Application
- 6.3 North America Artificial Heart Market Outlook by Country
- 6.3.1 The US Artificial Heart Market Outlook, 2021- 2032
- 6.3.2 Canada Artificial Heart Market Outlook, 2021- 2032
- 6.3.3 Mexico Artificial Heart Market Outlook, 2021- 2032
- 7. Europe Artificial Heart Market Size Outlook
- 7.1 Key Market Statistics, 2024
- 7.2 Europe Artificial Heart Market Trends and Growth Opportunities
- 7.2.1 Europe Artificial Heart Market Outlook by Type
- 7.2.2 Europe Artificial Heart Market Outlook by Application
- 7.3 Europe Artificial Heart Market Outlook by Country
- 7.3.2 Germany Artificial Heart Market Outlook, 2021- 2032
- 7.3.3 France Artificial Heart Market Outlook, 2021- 2032
- 7.3.4 The UK Artificial Heart Market Outlook, 2021- 2032
- 7.3.5 Spain Artificial Heart Market Outlook, 2021- 2032
- 7.3.6 Italy Artificial Heart Market Outlook, 2021- 2032
- 7.3.7 Russia Artificial Heart Market Outlook, 2021- 2032
- 7.3.8 Rest of Europe Artificial Heart Market Outlook, 2021- 2032
- 8. Asia Pacific Artificial Heart Market Size Outlook
- 8.1 Key Market Statistics, 2024
- 8.2 Asia Pacific Artificial Heart Market Trends and Growth Opportunities
- 8.2.1 Asia Pacific Artificial Heart Market Outlook by Type
- 8.2.2 Asia Pacific Artificial Heart Market Outlook by Application
- 8.3 Asia Pacific Artificial Heart Market Outlook by Country
- 8.3.1 China Artificial Heart Market Outlook, 2021- 2032
- 8.3.2 India Artificial Heart Market Outlook, 2021- 2032
- 8.3.3 Japan Artificial Heart Market Outlook, 2021- 2032
- 8.3.4 South Korea Artificial Heart Market Outlook, 2021- 2032
- 8.3.5 Australia Artificial Heart Market Outlook, 2021- 2032
- 8.3.6 South East Asia Artificial Heart Market Outlook, 2021- 2032
- 8.3.7 Rest of Asia Pacific Artificial Heart Market Outlook, 2021- 2032
- 9. South America Artificial Heart Market Size Outlook
- 9.1 Key Market Statistics, 2024
- 9.2 South America Artificial Heart Market Trends and Growth Opportunities
- 9.2.1 South America Artificial Heart Market Outlook by Type
- 9.2.2 South America Artificial Heart Market Outlook by Application
- 9.3 South America Artificial Heart Market Outlook by Country
- 9.3.1 Brazil Artificial Heart Market Outlook, 2021- 2032
- 9.3.2 Argentina Artificial Heart Market Outlook, 2021- 2032
- 9.3.3 Rest of South and Central America Artificial Heart Market Outlook, 2021- 2032
- 10. Middle East and Africa Artificial Heart Market Size Outlook
- 10.1 Key Market Statistics, 2024
- 10.2 Middle East and Africa Artificial Heart Market Trends and Growth Opportunities
- 10.2.1 Middle East and Africa Artificial Heart Market Outlook by Type
- 10.2.2 Middle East and Africa Artificial Heart Market Outlook by Application
- 10.3 Middle East and Africa Artificial Heart Market Outlook by Country
- 10.3.1 Saudi Arabia Artificial Heart Market Outlook, 2021- 2032
- 10.3.2 The UAE Artificial Heart Market Outlook, 2021- 2032
- 10.3.3 Rest of Middle East Artificial Heart Market Outlook, 2021- 2032
- 10.3.4 South Africa Artificial Heart Market Outlook, 2021- 2032
- 10.3.5 Egypt Artificial Heart Market Outlook, 2021- 2032
- 10.3.6 Rest of Africa Artificial Heart Market Outlook, 2021- 2032
- 11. Company Profiles
- 11.1 Leading 10 Companies
- Abbott Laboratories
- Abiomed
- Berlin Heart Inc
- BiVACOR Inc
- Calon Cardio-Technology Ltd
- Carmat
- CryoLife Inc
- Jarvik Heart Inc
- ReinHeart TAH GmbH
- SynCardia Systems Llc
- 11.2 Overview
- 11.3 Products and Services
- 11.4 SWOT Profile
- 12. Appendix
- 12.1 Subscription Options
- 12.2 Customization Options
- 12.3 Publisher Details
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.